Details werden geladen...
Alector Reports Second Quarter 2026 Financial Results and Provides Business Update | The Manila Times
Advancing the Alector Brain Carrier (ABC) blood-brain barrier platform across antibodies, enzymes, and siRNA, with AL137 advancing as Alector’s lead ABC-enabled anti-amyloid beta (Aβ) antibody program for Alzheimer’s disease (AD).
Ähnliche Seiten
Immunocore reports second quarter financial results and provides a business update | The Manila Times
https://www.manilatimes.net/2026/08/06/tmt-newswire/globenewswire/immunocore-reports-second-quarter-financial-results-and-provides-a-business-update/2399911Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/05/tmt-newswire/globenewswire/syndax-reports-second-quarter-2026-financial-results-and-provides-business-update/2398415Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/07/tmt-newswire/globenewswire/ardelyx-reports-second-quarter-2026-financial-results-and-provides-business-update/2400541Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/06/tmt-newswire/globenewswire/vaxcyte-reports-second-quarter-2026-financial-results-and-provides-business-update/2399379ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/06/tmt-newswire/globenewswire/adma-biologics-reports-second-quarter-2026-financial-results-and-provides-business-update/2399378